H.C.
The post Matinas BioPharma (MTNB) Receives a Buy from H.C. Wainwright appeared first on Smarter Analyst.
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Matinas BioPharma (MTNB) today and set a price target of $3.00. The companys shares closed last Monday at $0.77, close to its ...

https://www.smarteranalyst.com/new-blurbs/matinas-biopharma-mtnb-receives-a-buy-from-h-c-wainwright-2/

#SmarterAnalyst